Terumo Tsunami Coronary Stent To Withstand Wave Of DES Entries In Japan
This article was originally published in The Gray Sheet
Executive Summary
Results from European trials of Terumo's drug-eluting stent, using Biosensors' Biolimus A-9 anti-restenotic agent, S-Stent and polymer, will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2004 conference in Washington, D.C. Sept. 29-Oct. 2
You may also be interested in...
Terumo To End Guidewire And Sheath Distribution Deal With Boston Scientific
Terumo is creating its own U.S. sales force to sell guidewires and sheaths when its existing distribution arrangement with Boston Scientific expires in March 2006
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.